Testosterone therapy and cardiovascular risk

James P. Walsh, Anne C. Kitchens

Research output: Contribution to journalReview article

12 Scopus citations

Abstract

Endogenous testosterone levels are inversely associated with cardiovascular risk in older men and men with cardiovascular disease. Current data on cardiovascular outcomes of testosterone therapy include only observational studies and adverse event monitoring in short-term trials that were not designed to measure cardiovascular outcomes. These studies have yielded conflicting results, and some have raised concerns that testosterone therapy may increase cardiovascular risk. A well-designed, adequately powered, prospective trial will ultimately be required to clarify whether testosterone therapy impacts cardiovascular outcomes. This review describes the findings and limitations of recent studies of cardiovascular risk in older men on testosterone therapy and discusses some of the mechanisms through which testosterone may modify cardiovascular risk.

Original languageEnglish (US)
Pages (from-to)250-257
Number of pages8
JournalTrends in Cardiovascular Medicine
Volume25
Issue number3
DOIs
StatePublished - Apr 1 2015

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this